[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Asia-Pacific Fabry Disease Therapeutic Market Analysis 2012-2017 and Forecast 2018-2023

April 2018 | 107 pages | ID: ADE2259AA02EN
99Strategy

US$ 3,300.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SNAPSHOT

The Asia-Pacific Fabry Disease Therapeutic market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Fabry Disease Therapeutic by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
  • Enzyme Replacement Therapy
  • Alternative therapies
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
  • Amicus therapeutics
  • Shire
  • Genzyme-Sanofi
  • Protalix
  • Sanofi-Aventis LLC
  • Novartis Pharmaceuticals
  • Pfizer
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Amgen Inc.
  • Teva pharmaceutical Industries Ltd.
  • Merc & Co.
  • AbbVie Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Green Cross Corp.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
  • Hospitals
  • Clinics
  • Others
Region Coverage (Regional Production, Demand & Forecast by Regions etc.):
  • China
  • Japan & Korea
  • India
  • Southeast Asia
  • Oceania
1 INDUSTRY OVERVIEW

1.1 Fabry Disease Therapeutic Industry
  1.1.1 Overview
  1.1.2 Development of Fabry Disease Therapeutic
1.2 Market Segment
  1.2.1 By Product Type
  1.2.2 By Application
1.3 Asia-Pacific Overview

2 MAJOR COMPANIES LIST

2.1 Amicus therapeutics (Company Profile, Products & Services, Sales Data etc.)
2.2 Shire (Company Profile, Products & Services, Sales Data etc.)
2.3 Genzyme-Sanofi (Company Profile, Products & Services, Sales Data etc.)
2.4 Protalix (Company Profile, Products & Services, Sales Data etc.)
2.5 Sanofi-Aventis LLC (Company Profile, Products & Services, Sales Data etc.)
2.6 Novartis Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.7 Pfizer (Company Profile, Products & Services, Sales Data etc.)
2.8 Bristol-Myers Squibb Company (Company Profile, Products & Services, Sales Data etc.)
2.9 GlaxoSmithKline plc (Company Profile, Products & Services, Sales Data etc.)
2.10 Amgen Inc. (Company Profile, Products & Services, Sales Data etc.)
2.11 Teva pharmaceutical Industries Ltd. (Company Profile, Products & Services, Sales Data etc.)
2.12 Merc & Co. (Company Profile, Products & Services, Sales Data etc.)
2.13 AbbVie Inc. (Company Profile, Products & Services, Sales Data etc.)
2.14 Takeda Pharmaceutical Co. Ltd. (Company Profile, Products & Services, Sales Data etc.)
2.15 Green Cross Corp. (Company Profile, Products & Services, Sales Data etc.)

3 MARKET COMPETITION

3.1 Company Competition
3.2 Regional Market by Company

4 FABRY DISEASE THERAPEUTIC MARKET BY TYPE

4.1 By Type
  4.1.1 Enzyme Replacement Therapy
  4.1.2 Alternative therapies
4.2 Market Size
4.3 Market Forecast

5 MARKET DEMAND

5.1 Demand Situation
  5.1.1 Demand in Hospitals
  5.1.2 Demand in Clinics
  5.1.3 Demand in Others
5.2 Regional Demand Comparison
5.3 Demand Forecast

6 REGION OPERATION

6.1 Regional Production
6.2 Regional Market
6.3 by Region
  6.3.1 China
    6.3.1.1 By Type
    6.3.1.2 By Application
  6.3.2 Japan & Korea
    6.3.2.1 By Type
    6.3.2.2 By Application
  6.3.3 India
    6.3.3.1 By Type
    6.3.3.2 By Application
  6.3.4 Southeast Asia
    6.3.4.1 By Type
    6.3.4.2 By Application
  6.3.5 Oceania
    6.3.5.1 By Type
    6.3.5.2 By Application
6.4 Regional Forecast

7 MARKETING & PRICE

7.1 Price and Margin
  7.1.1 Price Trends
  7.1.2 Factors of Price Change
  7.1.3 Manufacturers Gross Margin Analysis
7.2 Marketing Channel

8 UPSTREAM & COST

8.1 Upstream
8.2 Cost

9 INDUSTRY ENVIRONMENT

9.1 Policy
9.2 Economics
9.3 Sociology
9.4 Technology

10 RESEARCH CONCLUSION

LIST OF TABLES

Table Product Segment of Fabry Disease Therapeutic
Table Asia-Pacific Fabry Disease Therapeutic Market 2012-2023, by Product Type, in USD Million
Table Application Segment of Fabry Disease Therapeutic
Table Asia-Pacific Fabry Disease Therapeutic Market 2012-2023, by Application, in USD Million
Table Amicus therapeutics Overview List
Table Fabry Disease Therapeutic Business Operation of Amicus therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shire Overview List
Table Fabry Disease Therapeutic Business Operation of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genzyme-Sanofi Overview List
Table Fabry Disease Therapeutic Business Operation of Genzyme-Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Protalix Overview List
Table Fabry Disease Therapeutic Business Operation of Protalix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi-Aventis LLC Overview List
Table Fabry Disease Therapeutic Business Operation of Sanofi-Aventis LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Pharmaceuticals Overview List
Table Fabry Disease Therapeutic Business Operation of Novartis Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Fabry Disease Therapeutic Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Overview List
Table Fabry Disease Therapeutic Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline plc Overview List
Table Fabry Disease Therapeutic Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Inc. Overview List
Table Fabry Disease Therapeutic Business Operation of Amgen Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva pharmaceutical Industries Ltd. Overview List
Table Fabry Disease Therapeutic Business Operation of Teva pharmaceutical Industries Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merc & Co. Overview List
Table Fabry Disease Therapeutic Business Operation of Merc & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Inc. Overview List
Table Fabry Disease Therapeutic Business Operation of AbbVie Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Co. Ltd. Overview List
Table Fabry Disease Therapeutic Business Operation of Takeda Pharmaceutical Co. Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Green Cross Corp. Overview List
Table Fabry Disease Therapeutic Business Operation of Green Cross Corp. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Asia-Pacific Fabry Disease Therapeutic Sales Revenue 2012-2017, by Company, in USD Million
Table Asia-Pacific Fabry Disease Therapeutic Sales Revenue Share, by Company, in USD Million
Table Asia-Pacific Fabry Disease Therapeutic Sales Volume 2012-2017, by Company, in Volume
Table Asia-Pacific Fabry Disease Therapeutic Sales Volume Share 2012-2017, by Company, in Volume
Table Major Company List of Enzyme Replacement Therapy
Table Major Company List of Alternative therapies
Table Asia-Pacific Fabry Disease Therapeutic Market 2012-2017, by Type, in USD Million
Table Asia-Pacific Fabry Disease Therapeutic Market 2012-2017, by Type, in Volume
Table Asia-Pacific Fabry Disease Therapeutic Market Forecast 2018-2023, by Type, in USD Million
Table Asia-Pacific Fabry Disease Therapeutic Market Forecast 2018-2023, by Type, in Volume
Table Fabry Disease Therapeutic Demand in Hospitals, 2012-2017, in USD Million
Table Fabry Disease Therapeutic Demand in Hospitals, 2012-2017, in Volume
Table Major Consumers in Hospitals
Table Fabry Disease Therapeutic Demand in Clinics, 2012-2017, in USD Million
Table Fabry Disease Therapeutic Demand in Clinics, 2012-2017, in Volume
Table Major Consumers in Clinics
Table Fabry Disease Therapeutic Demand in Others, 2012-2017, in USD Million
Table Fabry Disease Therapeutic Demand in Others, 2012-2017, in Volume
Table Major Consumers in Others
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Fabry Disease Therapeutic Demand Forecast 2018-2023, by Application, in USD Million
Table Fabry Disease Therapeutic Demand Forecast 2018-2023, by Application, in Volume
Table Fabry Disease Therapeutic Production 2012-2017, by Region, in USD Million
Table Fabry Disease Therapeutic Production 2012-2017, by Region, in Volume
Table Asia-Pacific Fabry Disease Therapeutic Market Size 2012-2017, by Region, in USD Million
Table Asia-Pacific Fabry Disease Therapeutic Market Size 2012-2017, by Region, in Volume
Table China Fabry Disease Therapeutic Market Size 2012-2017, by Type, in USD Million
Table China Fabry Disease Therapeutic Market Size 2012-2017, by Type, in Volume
Table China Fabry Disease Therapeutic Market Size 2012-2017, by Application, in USD Million
Table China Fabry Disease Therapeutic Market Size 2012-2017, by Application, in Volume
Table Japan & Korea Fabry Disease Therapeutic Market Size 2012-2017, by Country, in USD Million
Table Japan & Korea Fabry Disease Therapeutic Market Size 2012-2017, by Country, in Volume
Table Japan Fabry Disease Therapeutic Market Size 2012-2017, by Type, in USD Million
Table Japan Fabry Disease Therapeutic Market Size 2012-2017, by Type, in Volume
Table Japan Fabry Disease Therapeutic Market Size 2012-2017, by Application, in USD Million
Table Japan Fabry Disease Therapeutic Market Size 2012-2017, by Application, in Volume
Table India Fabry Disease Therapeutic Market Size 2012-2017, by Country, in USD Million
Table India Fabry Disease Therapeutic Market Size 2012-2017, by Country, in Volume
Table India Fabry Disease Therapeutic Market Size 2012-2017, by Type, in USD Million
Table India Fabry Disease Therapeutic Market Size 2012-2017, by Type, in Volume
Table India Fabry Disease Therapeutic Market Size 2012-2017, by Application, in USD Million
Table India Fabry Disease Therapeutic Market Size 2012-2017, by Application, in Volume
Table Southeast Asia Fabry Disease Therapeutic Market Size 2012-2017, by Country, in USD Million
Table Southeast Asia Fabry Disease Therapeutic Market Size 2012-2017, by Country, in Volume
Table Southeast Asia Fabry Disease Therapeutic Market Size 2012-2017, by Type, in USD Million
Table Southeast Asia Fabry Disease Therapeutic Market Size 2012-2017, by Type, in Volume
Table Southeast Asia Fabry Disease Therapeutic Market Size 2012-2017, by Application, in USD Million
Table Southeast Asia Fabry Disease Therapeutic Market Size 2012-2017, by Application, in Volume
Table Oceania Fabry Disease Therapeutic Market Size 2012-2017, by Country, in USD Million
Table Oceania Fabry Disease Therapeutic Market Size 2012-2017, by Country, in Volume
Table Oceania Fabry Disease Therapeutic Market Size 2012-2017, by Type, in USD Million
Table Oceania Fabry Disease Therapeutic Market Size 2012-2017, by Type, in Volume
Table Oceania Fabry Disease Therapeutic Market Size 2012-2017, by Application, in USD Million
Table Oceania Fabry Disease Therapeutic Market Size 2012-2017, by Application, in Volume
Table Fabry Disease Therapeutic Market Forecast 2018-2023, by Region, in USD Million
Table Fabry Disease Therapeutic Market Forecast 2018-2023, by Region, in Volume
Table Price Factors List
Table Upstream Segment of Fabry Disease Therapeutic

LIST OF FIGURES

Figure Fabry Disease Therapeutic Industry Chain Structure
Figure Asia-Pacific Fabry Disease Therapeutic Market Size and Growth Rate 2012-2023
Figure China Fabry Disease Therapeutic Market, by Company, in 2018
Figure Japan & Korea Fabry Disease Therapeutic Market, by Company, in 2018
Figure India Fabry Disease Therapeutic Market, by Company, in 2018
Figure Southeast Asia Fabry Disease Therapeutic Market, by Company, in 2018
Figure Oceania Fabry Disease Therapeutic Market, by Company, in 2018
Figure Asia-Pacific Fabry Disease Therapeutic Market Growth 2012-2017, by Type, in USD Million
Figure Asia-Pacific Fabry Disease Therapeutic Market Growth 2012-2017, by Type, in Volume
Figure China Fabry Disease Therapeutic Market Size and Growth 2012-2017, in USD Million
Figure China Fabry Disease Therapeutic Market Size and Growth 2012-2017, in Volume
Figure Japan & Korea Fabry Disease Therapeutic Market Size and Growth 2012-2017, in USD Million
Figure Japan & Korea Fabry Disease Therapeutic Market Size and Growth 2012-2017, in Volume
Figure India Fabry Disease Therapeutic Market Size and Growth 2012-2017, in USD Million
Figure India Fabry Disease Therapeutic Market Size and Growth 2012-2017, in Volume
Figure Southeast Asia Fabry Disease Therapeutic Market Size and Growth 2012-2017, in USD Million
Figure Southeast Asia Fabry Disease Therapeutic Market Size and Growth 2012-2017, in Volume
Figure Oceania Fabry Disease Therapeutic Market Size and Growth 2012-2017, in USD Million
Figure Oceania Fabry Disease Therapeutic Market Size and Growth 2012-2017, in Volume
Figure Marketing Channels Overview


More Publications